South & Central America Bariatric Surgeries Market Forecast to 2030 - Regional Analysis - by Type and End User

The South & Central America bariatric surgeries market was valued at US$ 282.51 million in 2022 and is expected to reach US$ 873.78 million by 2030; it is estimated to grow at a CAGR of 15.2% from 2022 to 2030.

Strategic Initiatives by Market Players Fuels the South & Central America Bariatric Surgeries Market

There has been a constant increase in the prevalence of obesity on a global level that has increased the demand for bariatric surgery devices. Various market players are also focused on product launches or strategic collaborations for the development of advanced products that help during bariatric surgeries and provide positive outcomes. There have been various recent developments, such as product launches, mergers, and acquisitions in recent years. A few of them are mentioned below:

• In June 2021, Ethicon launched a new advanced bipolar energy device, the ENSEAL X1 Curved Jaw Tissue Sealer. It enhances procedural efficiency by providing stronger sealing and greater access to more tissue than LigaSure Maryland. The device is used for colorectal, gynaecological, and bariatric surgeries and thoracic procedures.

:

In November 2022, Boston Scientific Corporation acquired Apollo Endosurgery Inc. with a total value of approximately US$ 615 million, which indicated a cash price of US$ 10 per share. The Apollo Endosurgery product portfolio includes devices used during endoluminal surgery (ELS) procedures to close and manage gastrointestinal

• In September 2021, Olympus acquired the new advanced bipolar surgical energy product range known as POWERSEAL. The POWERSEAL 5 mm Curved Jaw Tissue Sealer and Divider is a double-action device that meets the highest standards of medical performance for advanced bipolar surgical energy devices by delivering constant sealing reliability in an ergonomic and multifunctional design that promotes procedural efficiency. The POWERSEAL devices can be employed in numerous surgical procedures, including general, gynaecological, colorectal, bariatric, urological, thoracic, and vascular surgical procedures.

Thus, a surge in product launches, development, and strategic collaborations is likely to create considerable growth opportunities for the bariatric surgery devices market in the future.

South & Central America Bariatric Surgeries Market Overview

The South & Central America bariatric surgeries market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market growth in this region is primarily attributed increasing awareness regarding health and well-being.

According to an article published in Biomaterials Research, in 2020, Brazil is among the 10 countries in the world with the highest number of people with diabetes and was ranked 5th. By 2030, the prevalence of diabetes in the country is expected to increase from 6% to 7.8%, according to international estimates. Obesity is the major risk factor for diabetes, which is taken care of by performing bariatric surgeries, thereby driving the demand for bariatric surgery devices in Brazil.

Several market players are adopting organic strategies to stay competitive in the market. In October 2022, the Brazilian Health Regulatory Agency ANVISA approved Allurion to launch its gastric balloon technology-the Elipse Balloon-in Brazil. The Elipse Balloon can be placed in the stomach and removed without surgical procedure, anesthesia, or endoscopy.

Sout

h & Central America Bariatric Surgeries Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Bariatric Surgeries Market Segmentation

The South & Central America bariatric surgeries market is segmented into type, end user, and country.

Based on type, the South & Central America bariatric surgeries market is categorized adjustable gastric bands (AGB), sleeve gastrectomy, gastric bypass, biliopancreatic diversion with duodenal switch (bpd- ds), and others. The sleeve gastrectomy market segment held the largest share in 2022.

In terms of end user, the South & Central America bariatric surgeries market is bifurcated into hospitals and ambulatory surgical centers. The hospitals segment held a larger share in 2022.

Based on country, the South & Central America bariatric surgeries market is segmented Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America bariatric surgeries market in 2022.

Conmed Corp, Intuitive Surgical Inc, Medtronic Plc, Olympus Corp, and Reshape Lifesciences Inc are some of the leading companies operating in the South & Central America bariatric surgeries market.

Reasons to Buy

• Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America bariatric surgeries market.
• Highlights key business priorities in order to assist companies to realign their business strategies.
• The key findings and recommendations highlight crucial progressive industry trends in South & Central America bariatric surgeries market, thereby allowing players across the value chain to develop effective long-term strategies.
• Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
• Scrutinize in-depth South & Central America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
• Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution